Cited in boardrooms, legal proceedings & government briefings since 2017
Analysis of what the numbers mean — market sizing, regulation and the investment case, from the team behind PP’s reports. For the day’s news, see Business of Cannabis.
26 Mar 2026 · 6 min read
The headline shifts across 14 markets — where demand is accelerating, where regulation is the brake, and what it means for market entry.
Read the analysis
26 Mar 2026 · 4 min
The global medical cannabis market has shifted more in the past 12 months than in the previous five years combined. Canada rewrote the export record books, Germany doubled down on patient access following legalisation, and telemedicine quietly became the default way most…
9 Mar 2026 · 7 min
Prescription volumes, pricing and the telemedicine effect — reading the German market beyond the headlines.
9 Mar 2026 · 7 min
Cannabis telemedicine has become the dominant access channel in the world’s largest medical cannabis markets, but also their Achilles heel.
4 Mar 2026 · 8 min
The cannabis industry generates more market research than almost any sector of its size. A search for cannabis market data will return dozens of reports, forecasts, and dashboards — many priced at thousands of dollars, most making bold claims about market size and growth…
20 Feb 2026 · 5 min
Where the growth is concentrated across 31 markets, and how to read a forecast you can put in front of an IC.
3 Feb 2026 · 6 min
A supply shock, a correction, and the lesson for anyone modelling a single-market cannabis thesis.
18 Jan 2026 · 5 min
Category maturity, regulatory drag and the segments still compounding — a read on the numbers.
5 Jan 2026 · 6 min
Patient numbers are rising, but access remains the constraint. What the white paper data reveals.
18 Dec 2025 · 22 chapters
Glossary · Psychedelic Research: Clinical Trials, Timelines, and Key Research Groups · Therapy Practitioners in Psychedelic-Assisted Therapy · and 19 more
All chapters
16 Dec 2025 · 6 chapters
Industry Voices · Legal Landscape · Health & Science · and 3 more
All chapters
18 Oct 2025 · 6 min
The European CBD market continues to operate under a fragmented and inconsistent regulatory landscape , with tolerance levels varying significantly by country.
17 Oct 2025 · 2 min
Malta progressed from decriminalisation in 2015 (≤3.5 g; €50–€100 fines) to full legalisation in December 2021 , becoming the first EU member state to legalise adult-use cannabis .
16 Oct 2025 · 5 min
Switzerland began its first adult-use pilot sales in 2023 and now operates seven active projects , allowing enrolled participants to legally purchase cannabis under controlled conditions.
15 Oct 2025 · 2 min
Luxembourg became the first European Union member state to formally legalise adult-use cannabis when it passed its initial legislation in October 2021.
14 Oct 2025 · 4 min
Germany’s Cannabis Control Bill (CanG) came into effect on 1 April 2024 , marking the country’s most significant step toward cannabis legalisation in modern European history.
13 Oct 2025 · 3 min
The Netherlands’ legal adult-use cannabis experiment, officially known as the “Weed Experiment” ( Wietexperiment ), represents one of the most significant regulatory shifts in European cannabis policy.
12 Oct 2025 · 3 min
Medical cannabis in Norway is available only under strict exemption procedures administered by the Norwegian Medicines Agency (DMP) . Since November 2016, when new medical cannabis and approval exemption guidelines were issued, unregistered cannabis-based products — including…
11 Oct 2025 · 4 min
Medical cannabis in Sweden remains highly regulated and is only available through a strict individual licence process administered by the Swedish Medical Products Agency (Läkemedelsverket).
10 Oct 2025 · 3 min
Medical cannabis in Finland is classified as an unlicensed medicine, available only under strict control and through a special permit process administered by the Finnish Medicines Agency (Fimea) .
9 Oct 2025 · 3 min
In Estonia, medical cannabis is not formally legalised under a dedicated regulatory framework but can be accessed as an unlicensed medicine through a special permit process administered by the State Agency of Medicines (SAM) .
8 Oct 2025 · 3 min
Lithuania legalised the manufacture, import, export, and distribution of medical cannabis on 11 October 2018, with the law coming into effect on 1 May 2019 .
7 Oct 2025 · 4 min
Poland’s medical cannabis market is one of the fastest-growing in Central and Eastern Europe. The country’s estimated market size for 2025 is over €45 million, and it is projected to increase to €XXX million by 2029 ( see Market Sizing Forecasts for total figures ).
6 Oct 2025 · 4 min
Ukraine formally established its medical cannabis framework in August 2024, following the signing of the Cannabis Legalisation Law in February 2024.
5 Oct 2025 · 3 min
Romania represents one of Europe’s most restrictive medical cannabis environments, where legal provisions exist on paper but have not yet been implemented in practice.
4 Oct 2025 · 3 min
Cyprus has taken incremental steps toward medical cannabis legalisation, beginning in 2017 with legislation permitting the treatment of patients with advanced cancer using medical cannabis oil.
3 Oct 2025 · 4 min
After years of regulatory inertia, Greece’s medical cannabis market officially became operational in February 2024 , marking a long-awaited turning point for both patients and investors.
2 Oct 2025 · 3 min
North Macedonia has become one of Europe’s leading medical cannabis production and export hubs, despite having limited domestic patient access.
1 Oct 2025 · 3 min
Malta established its medical cannabis framework in 2018, introducing legislation that authorised both patient access and commercial cultivation and manufacturing for medicinal and research purposes.
30 Sept 2025 · 3 min
Croatia legalised the use of medical cannabis on 15 October 2015, becoming one of the first countries in Southeast Europe to authorise cannabis-based treatments.
29 Sept 2025 · 3 min
Slovenia is emerging as one of Europe’s most progressive medical cannabis markets, following a comprehensive legislative overhaul in mid-2025.
28 Sept 2025 · 3 min
Austria maintains one of Europe’s most tightly controlled medical cannabis frameworks, governed by the Austrian Narcotics Act (Suchtmittelgesetz, SMG).
27 Sept 2025 · 4 min
The Czech Republic remains one of Europe’s most liberal and progressive medical cannabis markets, underpinned by a pragmatic approach to drug policy and a strong domestic cultivation base.
26 Sept 2025 · 4 min
Denmark continues to serve as one of Europe’s most advanced and export-oriented medical cannabis markets, with a framework that balances pharmaceutical oversight and commercial opportunity.
25 Sept 2025 · 4 min
Germany remains Europe’s largest medical cannabis market, serving as both a regulatory model and commercial hub for the continent. Following the enactment of the Medical Cannabis Act (MedCanG) on 1 April 2024, Germany removed cannabis from its Narcotics Act (BtMG) , dramatically…
24 Sept 2025 · 3 min
Luxembourg established its medical cannabis framework on 20 July 2018, with the national programme becoming operational in February 2019. The system remains tightly regulated, with medical cannabis accessible only through trained physicians and hospital pharmacies.
23 Sept 2025 · 4 min
Switzerland has one of the longest-established medical cannabis frameworks in Europe, having first legalised treatment access in 2011 through a system of individual exemptions issued by the national health regulator, Swissmedic .
22 Sept 2025 · 4 min
Italy remains one of Europe’s most tightly controlled medical cannabis markets, operating under a government-monopolised system that regulates import, distribution, and domestic cultivation.
21 Sept 2025 · 3 min
The Netherlands holds a unique position in Europe’s cannabis landscape as the first country to establish a regulated medical cannabis framework, along with a state-supervised system for domestic cultivation and patient access.
20 Sept 2025 · 3 min
Belgium maintains one of Europe’s most restrictive medical cannabis frameworks, with only pure CBD permitted for medical use under magistral preparations. All other cannabis-derived products containing THC remain prohibited for prescription or sale.
19 Sept 2025 · 4 min
After several years of extending a small-scale medical cannabis trial, with limited engagement from regulators, France has now taken decisive steps towards establishing a permanent medical cannabis framework integrated into its national healthcare system.
18 Sept 2025 · 3 min
Spain has emerged as one of Europe’s largest medical cannabis producers, with substantial volumes of cannabis cultivated, imported, processed, and exported annually.
17 Sept 2025 · 3 min
Portugal’s estimated medical cannabis sales for 2025 are valued at over €280,000, with projections suggesting growth to €XXX million by 2029 (see Prohibition Partners Market Sizing Forecasts, 2025–2029 ) .
16 Sept 2025 · 3 min
The UK is one of Europe’s largest emerging medical cannabis markets. While the pace of regulatory change has been relatively slow, market development has accelerated rapidly since the legalisation of medical cannabis in 2018.
9 Sept 2025 · 3 min
Ireland has pursued a cautious and tightly controlled approach to medical cannabis . The launch of the Medical Cannabis Access Programme (MCAP) in 2019 marked a significant development, offering patients with specific health conditions a regulated pathway to treatment.
1 Aug 2025 · 3 min
The European cannabis industry has entered a new era of structural and regulatory transformation. Throughout 2024 and into 2025, the continent has witnessed landmark policy shifts, evolving commercial frameworks, and a surge in domestic and cross-border investment.
270 earlier pieces, from 2017 to 2024, are in the archive.
Browse the archiveOne curated brief a week on the developments that move the market — read by senior operators, investors and policymakers.
